Skip to content
← Back to this collection

PUBLICATIONS · 29134959

Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Nat Rev Clin Oncol
Publication date
2018 Mar
First author
Drilon A

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2018 Mar;15(3):150. doi: 10.1038/nrclinonc.2017.188.
    note
    Source null
    related pmid
    29182164
    relationship
    Erratum in

Authors and identifiers

  1. name
    Drilon A
    type
    Author
  2. name
    Hu ZI
    type
    Author
  3. name
    Lai GGY
    type
    Author
  4. name
    Tan DSW
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Drilon A
    type
    Author
  2. name
    Hu ZI
    type
    Author
  3. name
    Lai GGY
    type
    Author
  4. name
    Tan DSW
    type
    Author
bibliography ids
  1. nci-bib-de364fabde76a2ba986c63db
book metadata
content sha256
1b4a63ae113c703d3bcef0fcc86591fe87184866f9354e09e1efca337da5c1f3
document type
citation
dois
  1. 10.1038/nrclinonc.2017.175
electronic publication date
display
2017 Nov 14
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:29134959
immutable id
pubmed:29134959@1b4a63ae113c703d3bcef0fcc86591fe87184866f9354e09e1efca337da5c1f3
journal
abbreviation
Nat Rev Clin Oncol
issn electronic
1759-4782
issn print
1759-4774
issue
3
name
Nature reviews. Clinical oncology
nlm unique id
101500077
pages
151-167
volume
15
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2018 Mar;15(3):150. doi: 10.1038/nrclinonc.2017.188.
    note
    Source null
    related pmid
    29182164
    relationship
    Erratum in
outcomes validated
false
pmid
29134959
provenance
batch id
fb25b16edcb1373b70c1
provider
NCBI PubMed ESummary
record sha256
460aa43dcb78740d4ae7f9af9dc16c56d5c57c604a5228972df9f6d80794cbc9
response sha256
182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
retrieved at
2026-09-09T23:47:28.490065+00:00
publication date
display
2018 Mar
precision
month
year
2018
publication types
  1. Journal Article
  2. Research Support, Non-U.S. Gov't
  3. Review
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29134959/
title
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.

Preserved source evidence · Not medical advice